Literature DB >> 8383946

Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.

G Boivin1, A Erice, D D Crane, D L Dunn, H H Balfour.   

Abstract

We determined the acyclovir (ACV) susceptibilities of herpes simplex virus (HSV) isolates (n = 18) recovered from solid organ transplant patients after antiviral prophylaxis with ACV or ganciclovir. All isolates tested were susceptible to ACV (50% inhibitory concentration, < 1 microM). A clinical review of patients with HSV disease showed that all improved with specific anti-HSV therapy, and no recurrences were reported.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8383946      PMCID： PMC187669          DOI： 10.1128/AAC.37.2.357

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.

Authors:  J D Meyers; E C Reed; D H Shepp; M Thornquist; P S Dandliker; C A Vicary; N Flournoy; L E Kirk; J H Kersey; E D Thomas
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

2.  Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

Authors:  K S Erlich; J Mills; P Chatis; G J Mertz; D F Busch; S E Follansbee; R M Grant; C S Crumpacker
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

3.  Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus.

Authors:  E M Swierkosz; D R Scholl; J L Brown; J D Jollick; C A Gleaves
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

4.  Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir.

Authors:  P Collins; N M Oliver
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

5.  Effectiveness of oral acyclovir prophylaxis in renal transplant recipients.

Authors:  M Stoffel; J P Squifflet; Y Pirson; M Lamy; G P Alexandre
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

6.  Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.

Authors:  J C Wade; B Newton; N Flournoy; J D Meyers
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

Review 7.  Acyclovir prophylaxis for herpes simplex virus infection.

Authors:  D Gold; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

8.  Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.

Authors:  D H Shepp; P S Dandliker; N Flournoy; J D Meyers
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

9.  Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.

Authors:  L Seale; C J Jones; S Kathpalia; G G Jackson; M Mozes; M S Maddux; D Packham
Journal:  JAMA       Date:  1985-12-27       Impact factor: 56.272

10.  A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

Authors:  T C Merigan; D G Renlund; S Keay; M R Bristow; V Starnes; J B O'Connell; S Resta; D Dunn; P Gamberg; R M Ratkovec
Journal:  N Engl J Med       Date:  1992-04-30       Impact factor: 91.245
View more
  4 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

Authors:  A K Field; K K Biron
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

Review 3.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

4.  Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors.

Authors:  Nicolas Merienne; Juliette Le Douce; Emilie Faivre; Nicole Déglon; Gilles Bonvento
Journal:  Front Cell Neurosci       Date:  2013-07-05       Impact factor: 5.505
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.